EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction

Laura Patanè iD, Giuseppe Costantino, Marco Muscianisi, Clara De Francesco, Anna Viola, Walter Fries

Pharmacology Research & Perspectives · 2025

DOI: 10.1002/prp2.70143 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pharmacology Research & Perspectives, 2025. Verfasst von Laura Patanè und 5 weiteren Autor:innen. Beteiligte Einrichtung: IBD-Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase Deficiency, Hemolysis, Heterocyclic Compounds, 3-Ring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose‐6‐phosphate‐dehydrogenase (G6PD) deficiency is a heterogenous disorder that may lead to severe hemolytic events with the ingestion of fava beans and exposure to certain drugs. We report the first case of a 65‐year‐old male with Crohn's disease who developed a hemolytic crisis leading to hospitalization shortly after commencement of upadacitinib. An autoimmune condition was excluded but, as his family history was a positive for G6PD deficiency, very low levels of erythrocyte G6PD were detected. Upadacitinib was immediately discontinued with subsequent resolution of hemolysis. This case highlights the importance of rigorous pharmacological surveillance and suggests the need for further studies to clarify the pathogenetic mechanisms underlying this adverse reaction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucosephosphate Dehydrogenase DeficiencyHemolysisHeterocyclic Compounds, 3-RingHumansMaleAgedCrohn DiseaseGlucosephosphate Dehydrogenase

Substanzen

Heterocyclic Compounds, 3-RingGlucosephosphate Dehydrogenase

Autor:innen und Institutionen

  • IBD-Unit, Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  • Section of Gastroenterology and Hepatology, PROMISE, University of Palermo, Palermo, Italy.

ORCID-Profile: Laura Patanè

Zitieren

APA

Patanè, L., Costantino, G., Muscianisi, M., De Francesco, C., Viola, A., & Fries, W. (2025). Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction. Pharmacology Research & Perspectives. https://doi.org/10.1002/prp2.70143

Vancouver

Patanè L, Costantino G, Muscianisi M, De Francesco C, Viola A, Fries W. Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction. Pharmacology Research & Perspectives. 2025. doi:10.1002/prp2.70143

BibTeX
@article{Patan2025,
  author = {Patanè, Laura and Costantino, Giuseppe and Muscianisi, Marco and De Francesco, Clara and Viola, Anna and Fries, Walter},
  title = {Upadacitinib‐Induced Hemolysis in a Patient With Glucose‐6‐Phosphate Dehydrogenase Deficiency—A Possible Adverse Drug Reaction},
  journal = {Pharmacology Research & Perspectives},
  year = {2025},
  doi = {10.1002/prp2.70143}
}
Kostenlos starten →